Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Screening adolescents and young women.

Literature DB >> 23732030

Screening adolescents and young women.

Abstract

Recent guidelines from multiple organizations stress screening initiation no earlier than the age of 21 years and increased screening intervals for women aged 21 to 29 years. Primary prevention with human papillomavirus vaccination has the potential to significantly affect the development of high-grade cervical lesions, including cancer, and will likely affect screening guidelines in the future.

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Papillomavirus Vaccines

Year: 2013 PMID： 23732030 PMCID： PMC3672857 DOI： 10.1016/j.ogc.2013.02.007

Source DB: PubMed Journal: Obstet Gynecol Clin North Am ISSN： 0889-8545 Impact factor: 2.844

66 in total

1. Regression of low-grade squamous intra-epithelial lesions in young women.

Authors: Anna-Barbara Moscicki; Stephen Shiboski; Nancy K Hills; Kimberly J Powell; Naomi Jay; Evelyn N Hanson; Susanna Miller; K Lisa Canjura-Clayton; Sepidah Farhat; Jeanette M Broering; Teresa M Darragh
Journal: Lancet Date: 2004 Nov 6-12 Impact factor: 79.321

2. Does a water-based lubricant affect Pap smear and cervical microbiology results?

Authors: Michal Pawlik; Frank J Martin
Journal: Can Fam Physician Date: 2009-04 Impact factor: 3.275

3. The unsatisfactory ThinPrep® Pap Test™: analysis of technical aspects, most common causes, and recommendations for improvement.

Authors: Marilin Rosa; Premila Pragasam; Jinous Saremian; Ana Aoalin; William Graf; Amir Mohammadi
Journal: Diagn Cytopathol Date: 2012-07-26 Impact factor: 1.582

4. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.

Authors: A B Moscicki; N Hills; S Shiboski; K Powell; N Jay; E Hanson; S Miller; L Clayton; S Farhat; J Broering; T Darragh; J Palefsky
Journal: JAMA Date: 2001-06-20 Impact factor: 56.272

5. Development and duration of human papillomavirus lesions, after initial infection.

Authors: Rachel L Winer; Nancy B Kiviat; James P Hughes; Diane E Adam; Shu-Kuang Lee; Jane M Kuypers; Laura A Koutsky
Journal: J Infect Dis Date: 2005-01-21 Impact factor: 5.226

6. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Authors: Nubia Muñoz; Susanne K Kjaer; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Darron R Brown; Laura A Koutsky; Eng Hseon Tay; Patricía J Garcia; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Sven-Eric Olsson; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Marc Steben; F Xavier Bosch; Joakim Dillner; Warner K Huh; Elmar A Joura; Robert J Kurman; Slawomir Majewski; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine T Bryan; Lisa C Lupinacci; Katherine E D Giacoletti; Heather L Sings; Margaret K James; Teresa M Hesley; Eliav Barr; Richard M Haupt
Journal: J Natl Cancer Inst Date: 2010-02-05 Impact factor: 13.506

7. Human papillomavirus infection is transient in young women: a population-based cohort study.

Authors: M Evander; K Edlund; A Gustafsson; M Jonsson; R Karlsson; E Rylander; G Wadell
Journal: J Infect Dis Date: 1995-04 Impact factor: 5.226

8. Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women.

Authors: Anna-Barbara Moscicki; J Thomas Cox
Journal: J Low Genit Tract Dis Date: 2010-01 Impact factor: 1.925

Screening adolescents and young women.

1. Regression of low-grade squamous intra-epithelial lesions in young women.

2. Does a water-based lubricant affect Pap smear and cervical microbiology results?

3. The unsatisfactory ThinPrep® Pap Test™: analysis of technical aspects, most common causes, and recommendations for improvement.

4. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.

5. Development and duration of human papillomavirus lesions, after initial infection.

6. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

7. Human papillomavirus infection is transient in young women: a population-based cohort study.

8. Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women.

9. New insights into cervical cancer screening.

10. VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus.

1. Primary HPV testing recommendations of US providers, 2015.

Review 2. Addressing Anxiety and Fear during the Female Pelvic Examination.